Last viewed: RVNC


Prices are updated after-hours



nasdaq:RVNC Revance Therapeutics, Inc.

RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-8.5% 1m) (-47.8% 1y) (1.9% 2d) (-0.9% 3d) (-3.4% 7d) (NaN% volume)
http://www.revance.com
Sec Filling | Patents | 193 employees

Revance Therapeutics, Inc. is a clinical stage biotechnology company. It engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.

add to today's watch list email alert is off




aesthetic  

Press-releases


FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNC
Published: 2022-01-14 (Crawled : 05:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: 1.92% H: 0.0% C: 0.0%

ces era therapeutics deadline
REVANCE THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Revance Therapeutics, Inc. - RVNC
Published: 2022-01-13 (Crawled : 03:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: -2.73% H: 0.0% C: 0.0%

ces era therapeutics 100 deadline
Revance Provides Preliminary Fourth Quarter and Full Year 2021 Financial Results and a Corporate Update
Published: 2022-01-07 (Crawled : 14:00) - biospace.com/
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 0.0% C: 0.0%

financial results results
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.37% C: -5.83%

era therapeutics
RAAS Investors Have Opportunity to Lead Cloopen Group Holding Limited Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RAAS | $2.41 | twitter stocktwits trandingview |
Information
| | O: -0.37% H: 4.43% C: -5.17%
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.37% C: -5.83%

group
PLAYTIKA HOLDING CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Playtika Holding Corp.
Published: 2022-01-04 (Crawled : 15:00) - prnewswire.com
PLTK | $18.49 | twitter stocktwits trandingview |
| | O: -0.17% H: 1.33% C: -3.65%
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: -1.87% H: 1.91% C: -2.93%
IQ | $4.87 | twitter stocktwits trandingview |
Technology Services
| | O: -0.44% H: 0.22% C: -4.65%

ema ces
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RVNC
Published: 2022-01-01 (Crawled : 00:20) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology

era trial therapeutics deadline
ALERT: Revance Therapeutics, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RVNC
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.85% C: -0.67%

era therapeutics
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNC
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.85% C: -0.67%

ces era therapeutics deadline
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - RVNC
Published: 2021-12-30 (Crawled : 05:00) - prnewswire.com
RVNC | $14.88 | twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 3.8% C: -0.42%

era therapeutics deadline
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001479290-21-000141 4 2021-07-31 Sell S 20000 154302
0001479290-21-000141 4 2021-07-31 Sell S 34332 321611


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying